Systemic review on drug related hospital admissions – A pubmed based search  by Nivya, Kolli et al.
Saudi Pharmaceutical Journal (2015) 23, 1–8King Saud University
Saudi Pharmaceutical Journal
www.ksu.edu.sa
www.sciencedirect.comREVIEWSystemic review on drug related hospital
admissions – A pubmed based search* Corresponding author. Tel.: +91 8202922482, mobile: +91 7411338846; fax: +91 8202571998.
E-mail addresses: sonalsekhar@gmail.com, sonal.sekhar@manipal.edu (M. Sonal Sekhar).
Peer review under responsibility of King Saud University.
Production and hosting by Elsevier
1319-0164 ª 2013 Production and hosting by Elsevier B.V. on behalf of King Saud University.
http://dx.doi.org/10.1016/j.jsps.2013.05.006Kolli Nivya a, Vempati Sri Sai Kiran a, Nandita Ragoo a, B. Jayaprakash b,
M. Sonal Sekhar a,*a Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences, Manipal University, Manipal, Udupi,
Karnataka 576104, India
b Department of Medicine, Kasturba Medical College Hospital, Manipal University, Manipal, Udupi, Karnataka 576104, IndiaReceived 28 April 2013; accepted 22 May 2013





Systemic reviewAbstract Background: Drug related admissions have signiﬁcantly increased over the past few dec-
ades. According to various studies on drug related hospital admissions, it was estimated that
around 5–10% of hospital admissions were due to drug related problems (DRP), in which 50%
of them are avoidable.
Objective: The objective of the study was to derive results from various studies conducted on
drug related hospital admissions and have an overall view about the incidence, frequency, cost of
treatment, major causative drugs, problems for drug related hospital admissions, and preventable
drug related admissions and summarize the factors responsible for the occurrence of DRP.
Method: Relevant literatures related to ‘drug related hospital admissions’ were obtained from
PubMed database. Articles that were published from October 2007 to September 2012 were col-
lected. All the studies being shown in the search results were considered for the study irrespective
of the specialty department.
Results: A total of 366 articles were found based on the keyword ‘drug related hospital admis-
sion’, ‘drug related problem admission’, and ‘adverse drug event admissions’ search. Out of which
2 K. Nivya et al.49 articles were identiﬁed to be showing relevance to the study. Non-English, abstract-only articles,
and out-patient adverse drug reaction (ADR) studies were ﬁltered from 49 articles. Finally 15 arti-
cles were taken up for the study. Systemic analysis was made on these articles and the results were
summarized.
Conclusion: Most of DRP studies were retrospective, multicenter studies conducted in general
populations in Europe. The main objective of the studies was to estimate DRP frequency, incidence,
risk factors and trends of DRP hospital admissions. Anti-neoplastic agents, CVS drugs and CNS
drugs were related to most of the drug related problems. These studies concluded polypharmacy
and older age were the major risk factors for developing drug related problems. It was found that
the cost for the management of DRP was directly proportional to severity.
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A drug related problem (DRP) is deﬁned as an event or circum-
stance that involves a patient’s drug treatment that actually, or
potentially, interferes with the achievement of an optimal out-
come (Bhalla et al., 2003; Roxburgh and Degenhardt, 2008).
Problems associated with the drug use have a wide set of
factors that can be considered as DRP viz. adverse drug reac-
tions, drug interactions, untreated indication, inappropriate
drug selection, sub-therapeutic dosage, supra-therapeutic dos-
age, non-compliance and drug use without indication.
DRP admissions have been signiﬁcantly increased over the
past few decades. According to various studies on drug related
hospital admissions, it was estimated that around 5–10% of
hospital admissions were due to drug related problems, in
which 50% of them are avoidable (Nelson and Talbert, 1996;
Sekhar et al., 2011). DRP admissions need high attention as
DRP related admissions on an average accounted for 8.36%
(Conforti et al., 2012; Davies et al., 2010; Mene´ndez-Conde
et al., 2011; Posthumus et al., 2012; Rodenburg et al., 2011;
Singh et al., 2011; Stausberg and Hasford, 2011). Increased
use of medicines, existence of multiple inter current disease
states and polypharmacy are some of the risk factors for
DRPs. Gediatric population showed a high incidence of
DRP admissions. Pharmacological and pathological changes
leading to alteration in pharmacodynamic and pharmacoki-
netic parameters of drug absorption, distribution, metabolism
and excretion in elderly patients are believed to be the reasons
why gediatric population is the most affected group among
DRPs. Antiplatelets, anticoagulants, antineoplastics, immuno-
suppressive, diuretics, antidiabetics and antibiotics showed a
high proﬁle of drug related problems. Majority of DRP
admitted patients presented with chief complaints of weakness
due to dehydration, electrolyte imbalance; bleeding, GIdisturbances, anemia, hypoglycemia, secondary infections
etc. It has been noticed that drug related problems associated
with medications’ use have contributed to a major portion of
the health expenses in most of the countries (Carrasco-Garrido
et al., 2010; Dibben et al., 2011; Stausberg and Hasford, 2010;
Wu et al., 2010).
In a study conducted by Smith et al., the frequency of drug
‘reaction’ in hospitalized patients had been studied, and they
had shown that more the number of drugs, higher is the inci-
dence of DRPs. These authors attributed the increase in mor-
bidity due to polypharmacy, mainly when the patients are on
10 or more drugs. Twenty-four percentage of DRPs were
found out to be due to drug interactions (Smith et al., 1996).
2. Objective
The objective of the study was to derive results from various
studies conducted on drug related hospital admissions and
make an overall view about the incidence, frequency, cost in-
volved for treatment, major drugs contributing for the event,
complaints on drug related hospital admissions, and percent
preventable ADR admissions and summarize the factors
responsible for the occurrence of DRP.
3. Method
Relevant literatures related to ‘drug related hospital’ admissions
were obtained from PubMed database. Articles that were pub-
lished from October 2007 to September 2012 were collected.
All the studies being shown in the search results were considered
for the study irrespective of the specialty department. A total of
366 articles were found based on the keyword ‘drug related
hospital admission’, ‘drug related problem admission’, and
‘adverse drug event admissions’ search. Out of which 49 articles
Table 1 Background information of the drug related problem studies selected for the systemic review.
Study No. Study Country Study design Setting Study group Mean age
1. Posthumus et al. (2012)5 Netherlands Prospective Single-center Pediatrics 3 years 6 months
2. Conforti et al. (2012)6 Italy Prospective Single-center Geriatrics 81.9 years Women
(83.0 years) Men
(80.7 years)
3. Wu et al. (2012)19 Canada Retrospective cohort Multi-center Geriatrics 77.0 ± 7.1 years




49.8 ± 18.23 years
5. Stausberg and Hasford (2011)8 Germany Retrospective longitudinal Multi-center General
population
27.26 years




68.2 ± 16.1 years
7. Rodenburg et al. (2011)10 Netherlands Retrospective Multi-center General
population
–
8. Hartholt et al. (2010)18 Netherlands Retrospective Multi-center Geriatrics –
9. Davies et al. (2010)11 U.K Retrospective cohort Single-center General
population
62 years
10. Carrasco-Garrido et al. (2010)12 Spain Retrospective Multi-center General
population
–
11. Dibben et al. (2011)13 Scotland Retrospective Multi-center General
population
22.2 years
12. Wu et al. (2010)14 England Retrospective Multi-center General
population
70 years
13. Stausberg and Hasford, (2010)15 Germany Retrospective Multi-center General
population
–
14. Shamliyan (2010)20 US Retrospective Multi-center Geriatrics –
15. Brvar et al. (2009)16 Slovenia Retrospective Single-center General
population
65.6 (19–94) years
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lish, abstract-only articles, and out-patient ADR studies were
ﬁltered from 49 articles. Finally 15 articles were taken up for
our study. Systemic Analysis was made on these articles and
the results were summarized.4. Results and discussion
Out of 15 articles, four studies were prospective analysis which
was conducted at a single center, 11 studies were retrospective
data base screening out of which two studies were single center
based study. One study was conducted in pediatric population,
four in geriatric population and 10 studies were conducted in
general population (Table 1). More than two-third of the stud-
ies (12/15) were conducted in European countries, followed by
one study each in US, Canada and India.
One-third (5/15) of the articles’ primary objective was to
estimate frequency of DRP (Table 2) (Conforti et al., 2012;
Mene´ndez-Conde et al., 2011; Singh et al., 2011; Stausberg
and Hasford, 2011; Stausberg and Hasford, 2010). One-ﬁfth
(3/15) of the studies focused on analyzing trends in DRP hos-
pital admissions (Dibben et al., 2011; Hartholt et al., 2010; Wu
et al., 2010). Three studies were related to estimation of cost
involved to treat drug related hospital admissions (Mene´n-
dez-Conde et al., 2011; Wu et al., 2012). Two articles were each
on determining the incidence (Posthumus et al., 2012; Wu
et al., 2012) and risk factors associated with DRPs (Mene´n-
dez-Conde et al., 2011; Rodenburg et al., 2011). There were
few studies which made their objective differently viz, analyz-
ing the potential usefulness of ICD-10 coding (Stausberg and
Hasford, 2010); impact of ADRs on re-admissions (Davieset al., 2010); ﬁnding relation between gender and occurrence
of ADR related admissions; impact of homelessness as the risk
of death for young drug misusers (Dibben et al., 2011); ADE
(Adverse Drug Event) reporting, method of detection and ur-
gency of DRP admission (Brvar et al., 2009). DRP related
admissions are on an average accounted for 8.36% (Conforti
et al., 2012; Davies et al., 2010; Mene´ndez-Conde et al.,
2011; Posthumus et al., 2012; Rodenburg et al., 2011; Singh
et al., 2011; Stausberg and Hasford, 2011). Overall ADE re-
lated admission in female to male ratio was 1:0.74. ADR re-
lated hospital admission increased by 175% in males aged
P60 years and females 112% aged P60 years from 1981 to
2007 (Hartholt et al., 2010).
One-third of the studies reported that antineoplastic agents
(Brvar et al., 2009; Carrasco-Garrido et al., 2010; Mene´ndez-
Conde et al., 2011; Posthumus et al., 2012; Rodenburg et al.,
2011) as the major contributing drugs causing secondary infec-
tion, agranulocytosis, poisoning and constipation (Table 3).
Same number of studies showed similar results by CNS drugs
(Hartholt et al., 2010; Posthumus et al., 2012; Rodenburg
et al., 2011; Shamliyan, 2010; Wu et al., 2012). Seven studies
indicated that cardiovascular drugs (Brvar et al., 2009; Confor-
ti et al., 2012; Davies et al., 2010; Hartholt et al., 2010; Roden-
burg et al., 2011; Singh et al., 2011; Wu et al., 2010) as the
major contributing class in which two studies showed diuretics
(Conforti et al., 2012; Davies et al., 2010) as the major contrib-
uting drugs causing problems such as electrolyte imbalance.
Antidiabetic drugs (Brvar et al., 2009; Singh et al., 2011; Sham-
liyan, 2010), immunosuppressive drugs (Carrasco-Garrido
et al., 2010; Posthumus et al., 2012; Rodenburg et al., 2011)
antibiotics (Posthumus et al., 2012; Rodenburg et al., 2011;
Carrasco-Garrido et al., 2010) and anticoagulants (Carrasco-
Table 2 Summary of the drug related problem studies selected for the systemic review.
Study No. No. of subjects No. of DRP cases Duration Year of study Objective Conclusion
1. 683 258 4.5 months 2008 Incidence and characteristics of ADR
related admissions
ADR-related hospital admission occurred
in 6.9% of all acutely admitted pediatric
patients. All ADRs in the pediatric
wards and ICU, and oncology ward
were relatively mild, none of the
patients suﬀered permanent harm
2. 1215 1023 6 months 2009 Frequency of ADRs, both in hospital
admissions
and occurring
in hospital. To describe the types of
reactions and
associated drugs
11.1% of admissions were related to
ADRs. ADRs in patients during hospital
stay were 25%. Eighty four drugs were
responsible for hospital admissions. 60
ADRs identiﬁed and concluded that
ADRs are an important cause of hospital
admissions
3. Total population Data
Base screening
1.65 millions 5 years 2003–2007 Incidence and costs of emergency
department(ED)
visits related
to ADRs and to describe risk
factors for
experiencing severe ADRs
0.75% of total annual ED visits in adults
above 66 years were found to be
ADR-related,
and 21.6% of these patients were
hospitalized. In 2007, the cost of
ADR-related visits was $333 per visit
and $7528 per hospitalization for a total
annual cost of $13.6 million in Ontario,
or an estimated $35.7 million in Canada
4. 3560 118 6 months 2010 Frequency, severity and
classiﬁcation of DRP
resulting in hospitalization;
and to identify any patient,
prescriber, drug,
and system factors associated
with these events
Severity was classiﬁed as mild in 19
cases (16.1%), moderate in 91 cases
(77.12%) and severe in 08 cases (6.78%).
Most of the deﬁnite and possible DRP
were deﬁnitely preventable
5. Total population data
base screening
48 million 5 years 2003–2007 Estimate frequency and type of
drug-related
admissions and hospital-acquired
averse drug events (ADE)
5% of hospital admissions were found
to be at least possibly drug-induced and
0.7% very likely drug-induced. About 4.5%
of in-patients had experienced a
hospital-acquired ADE
6. 16,566 252 1 year Identify, classify and quantify the
frequency of ADR
related admissions.
To determine ADR preventability, risk
factors, costs and identify drugs that
are often involved
19.4% of admissions were the direct
consequence of ADR, 65% of which were
preventable. ADR associated cost was
€237,377 and mean cost per admission
was €4844
7. Total population Data
Base screening
9.28 million 6 years 2000–2005 Study diﬀerences in ADR-related
hospitalizations
between the sexes
ADR-related admissions are 0.41% of
all admissions in men and 43% of all
ADR-related admissions.0.47% of all













Study No. No. of subjects No. of DRP cases Duration Year of study Objective Conclusion
8. Total population Data
Base screening
0.36 million 26 years 1981–2007 Trends in ADR-related
hospitalizations
Overall number of ADR related hospital
admissions female: male is 1:0.74. ADR
related hospital admissions increased by
175% in males ageP 60 and 112% in
females agedP 60
9. 1000 (selected 1st
1000 pts who





1 year 2009–2010 Impact of ADRs on re-admission to
hospital after a
period as an inpatient
ADR contributing to admissions in 20.8%
of patients. Of the readmitted patients, 18.1%
patients had at least one ADR related readmission
10. Total population Data
Base screening
0.35 million 6 years 2001–2006 Estimate the burden of hospital
admissions,
along with the
associated total health cost
1.69% of all acute hospital admissions were
associated with ADRs. Cost generated
by patients due to ADR related
hospital admissions increased by 19.05%
from 2001 to 2006
11. Total population Data
Base screening
13,303 15 years 1986–2001 Estimate the additional impact of
homelessness on the risk of
death for young drug misusers
Immediately after a drug-related hospital
admission there was no diﬀerence in
survival between the homeless and those
with a ’ﬁxed address. Over a 3-year
period the risk for those who were
homeless was 3.5 times greater.
12. Total population Data
Base screening
0.55 million 10 years 1999–2009 Trends in hospital admissions
associated with ADRs
Between 1999 and 2008, the total
number of hospital admissions increased
by 28.3%, but the total number of admissions
due to ADRs increased by 76.8%
13. 11 millions – 1 year 2006 Examine the potential usefulness
of ICD-10 coded
diagnoses in routine hospital
data for the identiﬁcation of ADE
0.7% of hospital admissions were revealed by
routine data to be causally related to the
administration of a drug. In 5.3% of
admissions, there was at least a reason to
suspect such a causal relation
14. Total population Data
Base screening
0.32 million 8 years 2000–2007 Analyze trends in hospital admissions
due to ADEs
Total number of hospital admissions due
to ADEs increased from 36,199 in 2000 to
42,057 in 2007. Total hospital charges increased
from $393,618,776 in 2000 to $905,776,719 in 2007
15. Random selection of cases
(520 cases) from 17,230 in patients
30 1 year 2006 Evaluate the frequency of ADR related
admissions and its dependency
on reporting and method of detection,
urgency of admissions
ADRs cause 5.8% of admissions in medical
departments. The frequency of ADR causing
admissions detected by using an ICD-10 coding
system was 0.2% and no patient admitted due
to ADRs was reported to the national reporting
system. The recognized frequency of ADR
related admissions also depends on the







































Table 3 Major drugs contributing to DRP admissions, problems associated with the drug; and risk factors.
Study No. Major contributing drug Problems on admission Risk factors
1. Anti-neoplastic and immunomodulation drugs (6.7%),
vaccines, anti-infective for systemic use and medicines for
nervous system
Neutropenic fever (increased infection) Neutropenia due to cancer
chemotherapy
2. Diuretics, anti-thrombotic agents and ACE inhibitors Electrolyte imbalance, GI Disturbance,
Anemia and altered INR
Age, elderly people are at greater risk
3. Psychoactive agents, Opioids, sedatives and hypnotics Agranulocytosis (9.44%), heart failure
(3.64%) and coagulation defects (3.17%)
Polypharmacy (60.0%) Polyphysicians
(85%) Prescription re-ﬁlled in diﬀerent
pharmacies (50%)
4. Oral hypoglycemic agents and insulin, antihypertensive
agents and chemotherapy (antiretroviral)
– Noncompliance (46.6%)
5. – Enterocolitis due to Clostridium diﬃcile
infection was the most frequent cause of a
drug-related admission
–
6. Hormone therapy, anti-neoplastics and immunosuppressive
therapy accounted for 38%; digestive & metabolic treatment
90.5% and respiratory medicine 13.89%
Respiratory failure (36.7%) and
cardiovascular problems
Medical error, including both
prescription errors and medication
follow-up errors
7. Anti-neoplastic & immunosuppressive, anti-rheumatics, anti-
coagulants & Salicylates, CNS drugs, CVS drugs, steroids
and antibiotics
Agranulocytosis, GI Bleeding, poisoning
and constipation, osteoporosis,
hypoglycemia
Poly pharmacy, female gender
8. Cardiovascular agents, analgesics, hormones, water and
mineral acids, psychotropic drugs and systemic agents
Bleeding, GI symptoms, anemia, cardiac
system, pulmonary system, hypoglycemic
coma, electrolyte disturbances, UTI,
Cartilage disease, Agranulocytosis,
constipation and pulmonary embolism
Age (elderly patients at a higher risk)
9. Antiplatelet drugs, loop diuretics Bleeding and renal impairment Age (elderly patients at a higher risk)
10. Anti-neoplastics & immunosuppressive, adrenal
corticosteroids, anticoagulants and antibiotics
Neutropenia (5%), obstructive chronic
bronchitis (4.9%) and CHF (3.1%)
Age (elderly patients at a higher risk)
11. – – –
12. Systemic agents (19.2%), analgesic (13.3%) and CVS drugs
(12.9%)
Nephropathy, cardiovascular and mental
and behavior disorders
Multiple long term disease,
polypharmacy and age
13. – – –
14. Opioids, benzodiazepines, insulin, anti-diabetic drugs, anti-
coagulants




15. NSAIDs, acetyl salicylic acid, warfarin, CVS medication,
anti-neoplastic agents & immunosuppressive agents,
corticosteroids and anti-diabetic drugs
GI bleeding, hemorrhage, hypoglycemia,
electrolyte imbalance and secondary
infections
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were found as the major causal drug in 20% of the studies
causing problems like hypoglycemia, osteoporosis, GI bleed,
gastroenteritis and hemorrhage. Two studies each suggested
that systemic agents and analgesics as the major drugs causing
GI bleed and nephropathy. (Hartholt et al., 2010; Wu et al.,
2010) One study implied warfarin (Brvar et al., 2009) and ani-
platelets (Davies et al., 2010) as major contributing drugs caus-
ing complications such as bleeding.
Six studies indicated age (Brvar et al., 2009; Carrasco-Garr-
ido et al., 2010; Conforti et al., 2012; Davies et al.,2010; Har-
tholt et al., 2010; Wu et al., 2010) as the major risk factor. The
other risk factors included polypharmacy (Rodenburg et al.,
2011; Shamliyan, 2010; Wu et al., 2010, 2012), polyphysician
(Shamliyan, 2010; Wu et al., 2012), noncompliance (Singh
et al., 2011) and prescription errors (Mene´ndez-Conde et al.,
2011)(Table 3). Out of 15 articles, four articles also investi-
gated the severity of ADRs. In a prospective study on ADR
based on Le algorithm and Schumock algorithm for prevent-
ability, the severity of ADRs in patients exposed to cancer che-
motherapy was comparable with the severity of nonexposed
patients. All ADRs were classiﬁed as severe, due to hospital-
ization, but they were clinically mild cases, not resulting in per-
manent impairment to the patient or signiﬁcant hemodynamic
instability or directly or indirectly leading to patient death.
Only 10% of ADRs was avoidable in this study. In a study
by Singh et al., severity was classiﬁed as mild in 16.1% cases,
moderate in 77.12% cases and severe in 6.78% cases. Most of
the deﬁnite and possible DRPs were deﬁnitely preventable
(Singh et al., 2011). In a study by Brvar et al., 90% of ADRs
were potentially preventable (Brvar et al., 2009).
In a study by Mene´ndez-Conde et al., with regard to ADR
severity, 77.6% were level 4, 20.4% were level 5 and 2% were
level 6. They estimated ADR costs according to severity and
found a mean cost per admission were $342 for level 4 epi-
sodes, $438 for level 5 episodes and $726 for level 6 episodes.
They reported signiﬁcant differences in consumption of thy-
roid drugs (23.5% vs 4.9%, P= .003) and systemic corticoste-
roids (41.2% vs 11.3%, P= .001) for the unpreventable ADR
and non-ADR groups, respectively. There were also signiﬁcant
differences in the use of cytostatic drugs among patients with
both preventable and unpreventable ADRs (18.4% vs 6.4%,
P= .019) and in use of antiplatelets among patients with pre-
ventable ADRs (Brvar et al., 2009).
In another study byWu et al. on the incidence and economic
burden of ADRs among 7222 elderly patients in Ontario emer-
gency departments (EDs), found that severe ADRs were associ-
ated with age, sex, multiple drugs, comorbidity, polypharmacy,
newly prescribed drugs, recent ED visits, recent hospitalizations
and long term care (LTC) residents (Wu et al., 2012).
Shamliyan study reported that the average cost incurred for the
treatment ofDRP admissionwas $10,873 in 2000, which increased
to $ 21,536 per individual in the year 2007. Total cost for treating
DRPs in the year 2000 in US population was $ 393,618,776 that is
increased to 2.3 times in 2007 (Shamliyan, 2010).5. Conclusion
Majority of DRP studies were conducted in developed coun-
tries in Europe. Most of these were retrospective, multicenter
studies conducted in general populations. The primary objec-tive of the studies was to estimate DRP frequency, incidence,
risk factors and trends of DRP hospital admissions. Anti-neo-
plastic agents, CVS drugs and CNS drugs were identiﬁed to
precipitate most of the Drug Related Problems. Polyphar-
macy, polyphysician, non-compliance and prescription errors
were underlying reasons for developing DRPs. Few studies
classiﬁed DRPs based on severity and preventability. It was
found that the cost for the management of DRP was directly
proportional to Severity. It was quoted in an article that there
was 100% under reporting of ADRs. Many articles stated that
ADR related admissions were preventable up to 50% on an
average. Hospital could bring down therapy cost incurred to
treat DRP admissions to a greater extent. This gives an idea
on how much extent a clinical pharmacist could play a vital
role in preventing the drug related problems.6. Contributors
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